Triterpenoid compounds and application thereof in diabetes treatment drugs

A compound and drug technology, applied in the field of biomedicine, can solve the problems of high adverse reactions and weak activity, and achieve the effect of good α-glucosidase inhibitory activity, small molecular weight, and low dosage

Active Publication Date: 2014-03-26
HANGZHOU HUADONG MEDICINE GRP PHARMA RES INST +1
2 Cites 14 Cited by

AI-Extracted Technical Summary

Problems solved by technology

[0004] The present invention aims to overcome the defects of weak activity and high adverse reactions of current...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Abstract

The invention relates to two new triterpenoid compounds which are derived frominonotus obliquus leavening matters, have strong alpha-glycosidase inhibition activity, and can be used for the preparation of diabetes treatment drugs. The present invention also discloses a preparation method of the two new compounds and pharmaceutical compositions.

Application Domain

Technology Topic

DrugTriterpenoid Compound +4

Image

  • Triterpenoid compounds and application thereof in diabetes treatment drugs
  • Triterpenoid compounds and application thereof in diabetes treatment drugs
  • Triterpenoid compounds and application thereof in diabetes treatment drugs

Examples

  • Experimental program(6)

Example Embodiment

[0047] Example 1 Preparation method of compound 1 and 2
[0048] 1. Preparation of Inonotus obliquus fermented product by fermentation
[0049] 1) Bacteria:
[0050] The classification of Inonotus obliquus is named Fuscoporia obliqua (Pers: Fr.) Aoshima, which is preserved by the China Agricultural Microbial Culture Collection and Management Center, and the strain number is 1511C0001ACCC51184.
[0051] 2) Cultivation and preservation of seed strains
[0052] Solid medium: glucose 3g, potato extract powder 0.5g, KH2PO40.2g, soy peptone 0.5g, agar 1.5g, add water to 100mL, adjust pH to 6.0.
[0053] Solid culture method: Strains are inoculated on the slope of solid culture medium and cultivated at 28°C for 7-10 days.
[0054] After the solid culture is completed, place it on a slope at 4-10°C and refrigerate for later use.
[0055] 3), shake flask seed culture
[0056] Medium: glucose 3g, yeast extract powder 1.0g, soy peptone 1.0g, KH2PO40.2g, add water to 100mL, adjust pH to 6.0.
[0057] Liquid volume: 150mL medium in a 500mL triangular flask
[0058] Inoculation volume: 30% glycerol frozen hyphae 3ml
[0059] Culture temperature: 28℃
[0060] Training time: 7 days
[0061] Shaker speed: 150rpm
[0062] 4) Seed culture medium for seed tank
[0063] Medium: glucose 1.2kg, soybean powder 1kg, KH2PO4 80g, add water to 40L, adjust pH to 6.0.
[0064] Packing quantity: 40L of medium in a 100L seed tank, sterilized at 123°C for 30min.
[0065] Seed pot cultivation method: cultured 1500ml shake flask seed liquid is connected to the seed pot at 28°C for 7 days. During the cultivation process, the tank pressure is controlled: 0.05MPa, and the ventilation volume is 1:1 (V/V).
[0066] After culturing, microscopically check that the hyphae are strong, deep stained, free of bacteria, and bacteria concentration ≥15%
[0067] 5), fermentation tank culture
[0068] Medium: glucose 12kg, soybean powder 10kg, KH2PO4 0.8kg, L-glutamic acid 0.8kg, add water to 400L, adjust pH 5.5.
[0069] Capacity: 400L of culture medium in 1 ton fermenter
[0070] Fermentation tank culture method: The seed liquid on the cultivated 40L tank is connected to the fermentation tank at 28°C for 8 days. Control tank pressure during cultivation: 0.05 MPa, stirring speed 160 rpm, ventilation volume 1: 1.3 (V/V).
[0071] Judgment of the fermentation end point: the mycelium has deep staining, more vacuoles, and bacteria concentration ≥30%.
[0072] 2. Extraction and separation to obtain compounds 1 and 2
[0073] The fermentation product was filtered and dried to obtain a total of 6000 grams of mycelium of the fermentation product.
[0074] The fermentation broth of Inonotus obliquus was filtered to obtain mycelium. After the mycelium was dried (6Kg), it was extracted three times with 95% ethanol (30 liters each time). The extracts were combined and concentrated under reduced pressure (606g) . The above extract was suspended in 5 liters of water, extracted with petroleum ether 5 times (1 liter each time), and concentrated under reduced pressure to obtain a petroleum ether extract (160 g). The petroleum ether extract was passed through a silica gel column (silica gel 200-300 mesh, 1.5Kg), and an organic solvent was used for gradient elution (ie petroleum ether-acetone 20:1, petroleum ether-acetone 10:1, petroleum ether-acetone 5:1 , Petroleum ether-acetone 2:1, each solvent eluted 2 column volumes), collect petroleum ether-acetone (20:1) fraction (6g). The above part was purified by a reversed-phase C-18 column, and the elution conditions were (methanol-water 5:5, methanol-water 6:4, methanol-water 7:3, methanol-water 8:2, methanol-water 9: 1. Each solvent is eluted by 2 column volumes), the same parts are combined by thin-layer detection, and the same parts are combined and concentrated under reduced pressure to obtain compound 1 (240 mg) and compound 2 (350 mg).

Example Embodiment

[0075] Example 2: Physicochemical properties and spectral data of compound 1
[0076]
[0077] Compound 1: White amorphous powder; molecular formula is C 31 H 46 O 3;Optical rotation [α] 20 D +70.5(c0.088,CHCl 3 ); infrared (KBr)ν max 3567, 2964, 2928, 1714, 1185, 1125cm -1; Hydrogen spectrum and carbon spectrum (CDCl 3 ,500MHz) See Table 1 Mass spectrum (ESI) m/z: 467[M+H] +.

Example Embodiment

[0078] Example 3: Physicochemical properties and spectral data of compound 2
[0079]
[0080] Compound 2: White amorphous powder; molecular formula is C 31 H 48 O 3;Optical rotation [α] 20 D +100.0(c0.19,CHCl 3 ); infrared (KBr)ν max 3418,2934,1662,1595,1517,1458,1417,1189,1042,675cm -1; Hydrogen spectrum and carbon spectrum (CDCl 3 ,500MHz) See Table 1 Mass spectrum (ESI) m/z: 469[M+H] +.
[0081] Table 1 NMR data of compounds 1 and 2
[0082]
[0083]
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

no PUM

Description & Claims & Application Information

We can also present the details of the Description, Claims and Application information to help users get a comprehensive understanding of the technical details of the patent, such as background art, summary of invention, brief description of drawings, description of embodiments, and other original content. On the other hand, users can also determine the specific scope of protection of the technology through the list of claims; as well as understand the changes in the life cycle of the technology with the presentation of the patent timeline. Login to view more.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Similar technology patents

Preparation method for moxifloxacin intermediate (1S, 6R)-8-benzyl-7, 9-dioxy-2, 8-diazabicyclo [4.3.0] nonane

ActiveCN102408427AHigh chemical and optical puritySmall molecular weightOptically-active compound separationOrganic racemisationAqueous solutionOrganosolv
Owner:ZHEJIANG APELOA KANGYU PHARMA +2

Classification and recommendation of technical efficacy words

Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products